VSIG4 expressed on macrophages suppresses antitumor immune responses in patients with MDS and AML

Yuta Kaito

Presentation information

Poster Session

Fri. Oct, 12

Poster Session 1-5 MDS: Basic

Fri. Oct 12, 2018 5:30 PM - 6:10 PM Poster1 (Osaka International Convention Center, 3F Event Hall)

Chair: Hiromichi Matsushita (National Cancer Center Hospital Division of Pathology and Clinical Laboratories)

[PS1-5-8] VSIG4 expressed on macrophages suppresses antitumor immune responses in patients with MDS and AML

Yuta Kaito¹, Mariko Ishibashi², Yasuko Kuribayashi¹, Keiichi Moriya¹, Toshio Asayama¹, Mika Sunakawa¹, Ryosuke Kinoshita¹, Choi Inhak³, Koiti Inokuchi¹ (1.Department of Hematology, Nippon Medical School, Japan, 2.Department of Microbiology and Immunology, Nippon Medical School, Japan, 3.Department of Microbiology and Immunology, Inje University College, Korea)

Abstract password authentication.
Password is written on a program and abstract book.